2026 predictions: historic FDA shift, plausible mechanisms, bespoke tx, RFK Jr., biotechs, state AGs, peptides, embryos The Niche Orthopedic Use of BPC 157 Sports Med Review FDA Peptide Reclassification 2026 Amanecia Health The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York